These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 24625566

  • 1. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
    Verdoia M, Schaffer A, Barbieri L, Cassetti E, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):100-5. PubMed ID: 24625566
    [Abstract] [Full Text] [Related]

  • 2. MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting.
    Verdoia M, Schaffer A, Cassetti E, Barbieri L, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):532-7. PubMed ID: 24418373
    [Abstract] [Full Text] [Related]

  • 3. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Marino P, Bellomo G, Sinigaglia F, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Heart Vessels; 2015 Jan; 30(1):20-7. PubMed ID: 24297745
    [Abstract] [Full Text] [Related]

  • 4. Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Di Giovine G, Nardin M, Bellomo G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Diabetes Metab Res Rev; 2015 Jan; 31(1):85-92. PubMed ID: 24898423
    [Abstract] [Full Text] [Related]

  • 5. Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty.
    Verdoia M, Camaro C, Barbieri L, Schaffer A, Marino P, Bellomo G, Suryapranata H, De Luca G.
    Atherosclerosis; 2013 May; 228(1):136-41. PubMed ID: 23518179
    [Abstract] [Full Text] [Related]

  • 6. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Di Giovine G, Bellomo G, Marino P, Sinigaglia F, De Luca G.
    J Thromb Thrombolysis; 2014 Apr; 37(3):345-52. PubMed ID: 23793523
    [Abstract] [Full Text] [Related]

  • 7. Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.
    Verdoia M, Pergolini P, Barbieri L, Rolla R, Nardin M, Negro F, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Thromb Res; 2018 Apr; 164():17-23. PubMed ID: 29475177
    [Abstract] [Full Text] [Related]

  • 8. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
    Verdoia M, Secco GG, Barbieri L, Cassetti E, Schaffer A, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosreclerosis Study Group (NAS).
    Platelets; 2014 Apr; 25(5):367-72. PubMed ID: 24283589
    [Abstract] [Full Text] [Related]

  • 9. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Diabetes Metab Res Rev; 2014 May; 30(4):297-304. PubMed ID: 24829966
    [Abstract] [Full Text] [Related]

  • 10. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M, Schaffer A, Barbieri L, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Atherosclerosis; 2014 Sep; 236(1):169-74. PubMed ID: 25055060
    [Abstract] [Full Text] [Related]

  • 11. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Diabetes Complications; 2015 Sep; 29(4):517-22. PubMed ID: 25736187
    [Abstract] [Full Text] [Related]

  • 12. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow).
    Stone GW, Maehara A, Muller JE, Rizik DG, Shunk KA, Ben-Yehuda O, Genereux P, Dressler O, Parvataneni R, Madden S, Shah P, Brilakis ES, Kini AS, CANARY Investigators.
    JACC Cardiovasc Interv; 2015 Jun; 8(7):927-36. PubMed ID: 26003018
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M, Ceccon C, Nardin M, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):744-750. PubMed ID: 29656938
    [Abstract] [Full Text] [Related]

  • 14. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
    Negro F, Verdoia M, Nardin M, Suryapranata H, Kedhi E, Dudek D, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Atheroscler Thromb; 2021 Feb 01; 28(2):137-145. PubMed ID: 33342966
    [Abstract] [Full Text] [Related]

  • 15. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX, Li XL, Zhang MZ, Wang XW, Guo YL, Zhu CG, Ren Y, Li S, Zhang Y, Liu G, Xu RX, Dong Q, Li JJ.
    Scand J Clin Lab Invest; 2015 Nov 01; 75(7):568-77. PubMed ID: 26203960
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ, EVENT Registry Investigators.
    JACC Cardiovasc Interv; 2009 Nov 01; 2(11):1074-82. PubMed ID: 19926047
    [Abstract] [Full Text] [Related]

  • 17. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G, Sgueglia GA, Latib A, Crea F, Colombo A, CACTUS Study Group.
    Catheter Cardiovasc Interv; 2014 Jan 01; 83(1):E37-44. PubMed ID: 23813627
    [Abstract] [Full Text] [Related]

  • 18. Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
    Stetler J, Karatasakis A, Christakopoulos GE, Tarar MN, Amsavelu S, Patel K, Rangan BV, Roesle M, Resendes E, Grodin J, Abdullah S, Banerjee S, Brilakis ES.
    Catheter Cardiovasc Interv; 2016 Jul 01; 88(1):1-6. PubMed ID: 27014962
    [Abstract] [Full Text] [Related]

  • 19. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW, Yang HB, Chen YH, Ma JY, Qian JY, Ge JB.
    BMC Cardiovasc Disord; 2017 Feb 27; 17(1):69. PubMed ID: 28241795
    [Abstract] [Full Text] [Related]

  • 20. Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty.
    Verdoia M, Secco GG, Cassetti E, Schaffer A, Barbieri L, Perrone-Filardi P, Marino P, Suryapranata H, Sinigaglia F, De Luca G.
    Blood Coagul Fibrinolysis; 2014 Mar 27; 25(2):107-13. PubMed ID: 24480844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.